RECRUITING

Vasculitis Pregnancy Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.

Official Title

The Vasculitis Pregnancy Registry (V-PREG)

Quick Facts

Study Start:2015-11
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02593565

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 50 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Women 18 years of age or older with one of the following diseases may take part in the study:
  2. * Behçet's disease;
  3. * Central nervous system (CNS) vasculitis;
  4. * Cryoglobulinemic vasculitis (Cryoglobulinemia);
  5. * Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
  6. * Giant Cell (Temporal) Arteritis (GCA);
  7. * Granulomatosis with polyangiitis (also called Wegener's);
  8. * IgA vasculitis (Henoch-Schoenlein purpura);
  9. * Microscopic polyangiitis (MPA);
  10. * Polyarteritis nodosa (PAN);
  11. * Takayasu's arteritis (TAK);
  12. * Urticarial vasculitis;
  13. * Other/Suspected Diagnosis.
  14. 2. Women must be pregnant (self-report) at the time of enrollment into the registry.
  1. 1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
  2. 2. Unable to provide consent.

Contacts and Locations

Study Contact

Christine Yeung
CONTACT
christine.yeung@pennmedicine.upenn.edu
Carol McAlear, MA
CONTACT
cmcalear@upenn.edu

Principal Investigator

Megan Clowse, MD, MPH
STUDY_CHAIR
Duke University
Peter A Merkel, MD, MPH
STUDY_CHAIR
University of Pennsylvania

Study Locations (Sites)

University of South Florida Data Management and Coordinating Center
Tampa, Florida, 33612
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Megan Clowse, MD, MPH, STUDY_CHAIR, Duke University
  • Peter A Merkel, MD, MPH, STUDY_CHAIR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-11
Study Completion Date2026-12

Study Record Updates

Study Start Date2015-11
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • Vasculitis
  • Behcet's Disease
  • CNS Vasculitis
  • Cryoglobulinemic Vasculitis
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
  • Churg-Strauss Syndrome (CSS)
  • Granulomatosis With Polyangiitis (GPA)
  • Wegener's Granulomatosis
  • IgA Vasculitis
  • Henoch-Schoenlein Purpura (HSP)
  • Microscopic Polyangiitis (MPA)
  • Polyarteritis Nodosa (PAN)
  • Takayasu Arteritis (TAK)
  • Urticarial Vasculitis
  • Systemic Vasculitis